Benefits
Balanced Omega Fatty Acid Profile
Hemp seed oil has ~3:1 omega-6 to omega-3 ratio — more favorable than most vegetable oils (sunflower 100:1, corn 50:1). Closer to evolutionarily appropriate ratios. Provides both ALA (omega-3) and GLA (omega-6) in plant-based form.
ALA Plant Omega-3 (Limited Conversion to EPA/DHA)
ALA is plant omega-3; converts to EPA at ~5-10% efficiency, to DHA at <1% efficiency in adults. Hemp seed oil provides ALA but is not efficient EPA/DHA source. ALA itself has some independent benefits (cardiovascular, inflammation).
GLA (Gamma-Linolenic Acid) Source
Hemp contains modest GLA — converted to DGLA (di-homo-gamma-linolenic acid) and series-1 anti-inflammatory eicosanoids. Smaller GLA content than borage or evening primrose but useful supplement.
Skin Health (Topical and Oral)
Topical hemp seed oil supports skin barrier function. Oral use may improve skin moisture and reduce eczema symptoms — trial in atopic dermatitis showed improvements. Mechanism: essential fatty acid contribution to skin barrier.
Modest Anti-Inflammatory Effects
Combination of ALA + GLA provides modest anti-inflammatory effects via eicosanoid modulation. Effects much smaller than fish oil's EPA/DHA. Reasonable supplementary effect.
Mechanism of action
Essential Fatty Acid Provision
Provides essential linoleic acid (LA) and alpha-linolenic acid (ALA) — both can't be synthesized by humans and must come from diet. Hemp seed oil's balanced ratio supports proper essential fatty acid intake.
Limited ALA-to-EPA/DHA Conversion
ALA → EPA conversion ~5-10%; ALA → DHA conversion <1%. Conversion lower in men than women, lower with age, lower with high LA intake. For meaningful EPA/DHA, fish oil or algal oil more reliable.
GLA → DGLA Pathway
GLA is metabolized to DGLA (delta-6 desaturase converts LA to GLA, then elongase converts GLA to DGLA). DGLA produces series-1 prostaglandins (PGE1) which are anti-inflammatory, vasodilatory.
Skin Barrier Support
Essential fatty acids support stratum corneum lipid composition; deficiency impairs skin barrier function. Both topical and oral hemp seed oil support skin lipid status.
Clinical trials
Clinical trial crossover trial of hemp seed oil (30 mL/day) vs olive oil placebo in 20 atopic dermatitis patients for 8 weeks each.
20 atopic dermatitis patients.
Hemp seed oil significantly reduced skin dryness, itchiness, and reduced topical medication use vs olive oil. In this single small (n=20) crossover trial, dietary hemp seed oil reduced skin dryness, itchiness, and topical medication use vs olive oil, suggesting adjunctive support for atopic dermatitis; larger trials are lacking. Modest effect size.
One 8-week randomized trial of hemp seed oil (Del Bo' 2019) in children and adolescents with primary hyperlipidemia, measuring erythrocyte fatty-acid composition, the omega-3 index, and the lipid profile.
Children and adolescents with primary hyperlipidemia (Del Bo' 2019).
In the cited 8-week randomized trial in children and adolescents with primary hyperlipidemia (Del Bo' 2019), hemp seed oil improved the erythrocyte omega-3 index and fatty-acid composition of phospholipids but did NOT change the lipid profile (total, LDL, or HDL cholesterol). Any fatty-acid effect is smaller than that of fish oil's EPA/DHA. Hemp positioned as nutritional support rather than therapeutic intervention.